Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of IVACFLU-A/H5N1 Vaccine in Healthy Adults
NCT02612909Phase 3Completed
- Sponsor
- Institute of Vaccines and Medical Biologicals
- Start
- Mar 2017
- Primary completion
- Aug 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of IVACFLU-A/H5N1 in Avian Influenza (AI), sponsored by Institute of Vaccines and Medical Biologicals. Started Mar 2017; status: completed.
02
Drugs
IVACFLU-A/H5N1
03
Conditions
Avian Influenza (AI)
Beyond the preview
Go deeper on NCT02612909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02612909.